Sichuan Em Technology Co., Ltd. (601208.SS)
Mianyang, CN
Sichuan Em Technology Co., Ltd., based in Mianyang, China, is a company primarily engaged in the research, development, production, and sale of advanced materials across China. The firm offers a wide array of specialized products, including various types of films such as electrical and electronic insulation films, optical PET films, polyester films, capacitor PP films, PVB resins and films, as well as polycarbonate and polypropylene films and sheets. Additionally, its extensive portfolio features electrical insulation materials, composite materials, thermosetting composites, flame retardant substances, and unique resins. The company also supplies PET chips, adhesive tapes, protection films, fabricated products, resin specifically for CCL (Copper Clad Laminates), and active pharmaceutical ingredients (APIs) along with their intermediates.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -8.14% | -7.41% | +27.75% | +43.06% | +145.82% | +84.57% | +456.17% | +315.97% | +314.59% | +722.37% | +470.13% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+15.9% ★ Q1'26: +27.2% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+57.9% ★ Q1'26: +125.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-4.9% Q1'26: -4.8% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+7.5% ★ Q1'26: +9.0% (vs Q1'25)
-
ROIC Chemicals: +3.4%+5.4% ★ Q1'26: +5.3% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-0.1% ★ Q1'26: -12.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×2.48× Q1'26: 6.33× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 4 EPS Ana. |
Dec 2027 4 Rev. Ana. 5 EPS Ana. |
Dec 2028 4 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.41B
est: 1.41B (-0.2%)
|
1.67B
est: 1.41B (+18.8%)
|
1.73B
est: 1.69B (+2.7%)
|
1.64B
est: 2.08B (-20.8%)
|
1.74B
est: 2.57B (-32.6%)
|
1.88B
est: 2.16B (-12.8%)
|
3.25B
est: 3.18B (+2.3%)
|
3.64B
est: 4.39B (-17.2%)
|
3.74B
est: 4.03B (-7.3%)
|
4.47B
est: 4.17B (+7.1%)
|
5.18B
est: 5.38B (-3.8%)
|
6.83B
6.29B – 7.75B
+26.8% YoY
|
8.60B
7.28B – 10.67B
+26.0% YoY
|
10.30B
10.14B – 10.46B
+19.8% YoY
|
| EBITDA |
200.49M
est: 210.50M (-4.8%)
|
224.37M
est: 210.50M (+6.6%)
|
205.30M
est: 252.18M (-18.6%)
|
153.58M
est: 310.14M (-50.5%)
|
189.31M
est: 384.54M (-50.8%)
|
318.30M
est: 322.09M (-1.2%)
|
591.80M
est: 474.33M (+24.8%)
|
551.82M
est: 656.47M (-15.9%)
|
540.86M
est: 591.59M (-8.6%)
|
443.60M
est: 612.45M (-27.6%)
|
808.76M
est: 790.19M (+2.4%)
|
1.00B
923.56M – 1.14B
+26.8% YoY
|
1.26B
1.07B – 1.57B
+26.0% YoY
|
1.51B
1.49B – 1.54B
+19.8% YoY
|
| EBIT |
91.09M
est: 114.38M (-20.4%)
|
82.61M
est: 114.38M (-27.8%)
|
65.91M
est: 137.03M (-51.9%)
|
15.01M
est: 168.53M (-91.1%)
|
60.02M
est: 208.96M (-71.3%)
|
184.05M
est: 175.02M (+5.2%)
|
379.90M
est: 257.75M (+47.4%)
|
307.79M
est: 356.72M (-13.7%)
|
244.66M
est: 308.52M (-20.7%)
|
183.60M
est: 319.40M (-42.5%)
|
386.79M
est: 412.09M (-6.1%)
|
522.41M
481.65M – 593.18M
+26.8% YoY
|
658.02M
557.13M – 817.08M
+26.0% YoY
|
788.24M
775.93M – 800.56M
+19.8% YoY
|
| Net Income |
61.11M
est: 146.58M (-58.3%)
|
41.68M
est: 146.58M (-71.6%)
|
99.30M
est: 130.45M (-23.9%)
|
32.15M
est: 249.18M (-87.1%)
|
72.87M
est: 178.82M (-59.2%)
|
175.49M
est: 219.87M (-20.2%)
|
334.28M
est: 450.97M (-25.9%)
|
415.01M
est: 473.98M (-12.4%)
|
326.40M
est: 268.32M (+21.6%)
|
181.02M
est: 335.19M (-46.0%)
|
285.44M
est: 380.39M (-25.0%)
|
713.61M
574.90M – 775.05M
+87.6% YoY
|
1.37B
654.06M – 1.66B
+92.1% YoY
|
1.81B
823.93M – 2.34B
+32.2% YoY
|
| SGA |
203.36M
est: 81.92M (+148.2%)
|
233.98M
est: 81.92M (+185.6%)
|
162.78M
est: 98.14M (+65.9%)
|
154.21M
est: 120.70M (+27.8%)
|
178.15M
est: 149.66M (+19.0%)
|
156.63M
est: 125.35M (+25.0%)
|
185.16M
est: 184.60M (+0.3%)
|
189.36M
est: 255.49M (-25.9%)
|
204.30M
est: 180.52M (+13.2%)
|
195.55M
est: 186.88M (+4.6%)
|
85.41M
est: 241.12M (-64.6%)
|
305.66M
281.81M – 347.07M
+26.8% YoY
|
385.01M
325.98M – 478.07M
+26.0% YoY
|
461.20M
454.00M – 468.41M
+19.8% YoY
|
| EPS |
0.08
est: 0.15 (-50.0%)
|
0.05
est: 0.15 (-65.0%)
|
0.12
est: 0.14 (-10.1%)
|
0.04
est: 0.26 (-84.9%)
|
0.09
est: 0.19 (-50.6%)
|
0.22
est: 0.23 (-3.2%)
|
0.40
est: 0.47 (-15.5%)
|
0.46
est: 0.50 (-7.5%)
|
0.37
est: 0.31 (+20.5%)
|
0.20
est: 0.34 (-40.5%)
|
0.30
est: 0.35 (-15.4%)
|
0.75
0.60 – 0.81
+110.7% YoY
|
1.21
0.69 – 1.75
+61.7% YoY
|
1.62
0.87 – 2.46
+33.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-28 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-25 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | KraneShares ICBCCS S&P China 500 Index UCITS ETF CHIN.L | 0.10% | 74.9K | 0.55% |
| 2 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.90M | 0.06% |
| 3 | Dimensional - Emerging Markets Value ETF DFEV | 0.01% | 222.6K | 0.46% |
| 4 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.01% | 692.4K | 0.39% |
| 5 | Amundi Prime Emerging Markets UCITS ETF DR (C) PRAM.L | 0.01% | 108.3K | 0.10% |
| 6 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 61.9K | 0.48% |
| 7 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 139.7K | 0.26% |
| 8 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 6.89M | 0.06% |
| 9 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 304.9K | 0.28% |
| 10 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 244.1K | 0.29% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chunming Luo | Deputy General Manager | — | male |
| Dan Yan | Accounting Supervisor | — | — |
| Gang Li | General Manager | — | male |
| Guoren Jing | Deputy GM & Chief Financial Officer | — | male |
| Jie Chen | Board Secretary | — | male |
| Qiang Shi | Deputy General Manager | — | male |
| Wenquan Li | Deputy General Manager | — | male |
| You Zhou | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 601208.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
